Merit Medical Systems | MMSI - 市值



金融业
股票价格
USD
资产
USD 2.69B
现金及等价物
USD 446.4M
销售成本
USD 198.58M
流动资产
USD 1.04B
流动负债
USD 239.76M
债务
USD 821.15M
EBIT
USD 54.2M
EBITDA
USD 97.23M
员工
7.4K
EPS每股收益
USD 1.04
股本和储备
USD 1.58B
销售毛利
USD 195.35M
债务利息支出
USD 6.36M
利息收入
USD 3.62M
贷款资金
USD 734.04M
市值
USD 3.95B
净收入
USD 27.76M
营业费用
USD 339.74M
营业利润
USD 54.2M
普通股股本
USD 59.29M
PE价格收益
39.13
税前利润
USD 73.18M
销售收入
USD 393.9M
销售和管理费用
USD 114.83M
股票
USD 333.71M
贸易债权人
USD 60.55M
应收帐款人
USD 223.61M


市值 更改 日
3M USD 85.05B 2.4B 2025-12
Abbott USD 217.86B 15.25B 2025-12
AngioDynamics USD 511M 94M 2025-09
Anika Therapeutics USD 139M 3M 2025-12
AtriCure USD 1.97B 215M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Boston Scientific USD 141.35B 3.31B 2025-12
Cooper Companies USD 15.95B 2.05B 2025-12
Dexcom USD 25.88B 503M 2025-12
Edwards Lifesciences USD 49.47B 3.81B 2025-12
Globus Medical USD 11.69B 3.95B 2025-12
Haemonetics USD 3.76B 1.44B 2025-12
Hologic USD 16.62B 1.67B 2025-12
ICU Medical USD 3.52B 561M 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
J&J USD 500.24B 67.44B 2025-12
Merit Medical Systems USD 5.23B 297M 2025-12
Olympus JPY 2.21T 80.41B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
STAAR Surgical USD 1.17B 149M 2025-12
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12